{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:05Z","timestamp":1786980305232,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.gtc.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T19:48:48Z","timestamp":1781552928000},"page":"389-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Changing Epidemiology of Clostridioides difficile Infection"],"prefix":"10.1016","volume":"55","author":[{"given":"Kanika","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Feuerstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gtc.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-81-4-429","article-title":"Clindamycin-associated colitis. A prospective study","volume":"81","author":"Tedesco","year":"1974","journal-title":"Ann Intern Med"},{"issue":"8068","key":"10.1016\/j.gtc.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0140-6736(78)93001-5","article-title":"Aetiology of antimicrobial-agent-associated colitis","volume":"1","author":"George","year":"1978","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.gtc.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1021\/acsinfecdis.0c00290","article-title":"Clostridioides difficile infection: the challenge, tests, and guidelines","volume":"6","author":"Lyerly","year":"2020","journal-title":"ACS Infect Dis"},{"issue":"14","key":"10.1016\/j.gtc.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/CMR.00016-13","article-title":"Diagnosis of Clostridium difficile infection: an ongoing conundrum for Clinicians and for clinical laboratories","volume":"26","author":"Burnham","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/cid\/ciu419","article-title":"Bartlett: contributions to the discovery of Clostridium difficile antibiotic-associated diarrhea","volume":"59","author":"Gorbach","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.001_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archpedi.1935.01970020105010","article-title":"Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, BACILLUS difficilis","volume":"49","author":"HALL","year":"1935","journal-title":"Am J Dis Child"},{"issue":"10","key":"10.1016\/j.gtc.2026.05.001_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","article-title":"Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia","volume":"298","author":"Bartlett","year":"1978","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/clind\/15.4.573","article-title":"Antibiotic-associated diarrhea","volume":"15","author":"Bartlett","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"8052-8053","key":"10.1016\/j.gtc.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(77)90363-4","article-title":"Pseudomembranous colitis: presence of clostridial toxin","volume":"2","author":"Larson","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0016-5085(80)90851-3","article-title":"Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis","volume":"78","author":"Bartlett","year":"1980","journal-title":"Gastroenterology"},{"issue":"6153","key":"10.1016\/j.gtc.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bmj.2.6153.1667","article-title":"Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea","volume":"2","author":"Keighley","year":"1978","journal-title":"Br Med J"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/iai.56.9.2299-2306.1988","article-title":"Actin-specific ADP-Ribosyltransferase produced by a Clostridium difficile strain","volume":"56","author":"Popoff","year":"1988","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1203.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3201\/eid1406.071447","article-title":"Increase in adult clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005","volume":"14","author":"Zilberberg","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.gtc.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile--more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JCM.02563-05","article-title":"Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada","volume":"44","author":"MacCannell","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"23","key":"10.1016\/j.gtc.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N Engl J Med"},{"issue":"9491","key":"10.1016\/j.gtc.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","article-title":"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe","volume":"366","author":"Warny","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gtc.2026.05.001_bib21","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/j.1572-0241.2007.01539.x","article-title":"Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1\/027","volume":"102","author":"Pepin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2026.05.001_bib22","series-title":"Clostridium difficile infections (CDI) in hospital stays, 2009. Healthcare cost and utilization project (HCUP) statistical briefs","author":"Lucado","year":"2006"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(10)70080-3","article-title":"Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread","volume":"10","author":"Clements","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.gtc.2026.05.001_bib24","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib25","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2009.02.073","article-title":"Clostridium difficile infection caused by the epidemic BI\/NAP1\/027 strain","volume":"136","author":"O'Connor","year":"2009","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.gtc.2026.05.001_bib26","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.001_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.25252","article-title":"Antibiotic use and the risk of hospital-onset Clostridioides difficile infection","volume":"8","author":"Gilboa","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.001_bib28","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/jac\/dkab151","article-title":"Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study","volume":"76","author":"Schechner","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.001_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02169-19","article-title":"Antibiotic exposure and risk for hospital-associated Clostridioides difficile infection","volume":"64","author":"Webb","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/dkr508","article-title":"Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics","volume":"67","author":"Hensgens","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"16","key":"10.1016\/j.gtc.2026.05.001_bib32","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"issue":"10 Suppl 2","key":"10.1016\/j.gtc.2026.05.001_bib33","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"Guideline for isolation precautions: preventing transmission of infectious agents in health care settings","volume":"35","author":"Siegel","year":"2007","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.001_bib34","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/j.gastro.2016.12.035","article-title":"Asymptomatic carriers contribute to nosocomial Clostridium difficile infection: a cohort study of 4508 patients","volume":"152","author":"Blixt","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gtc.2026.05.001_bib35","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1038\/s41591-023-02549-4","article-title":"Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit","volume":"29","author":"Miles-Jay","year":"2023","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.gtc.2026.05.001_bib36","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/cid\/ciz626","article-title":"Predictors of Clostridioides difficile infection among asymptomatic, colonized patients: a retrospective cohort study","volume":"70","author":"Poirier","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ajg.2015.22","article-title":"Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis","volume":"110","author":"Zacharioudakis","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.001_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/ice.2023.18","article-title":"Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update","volume":"44","author":"Kociolek","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.001_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3201\/eid2805.212023","article-title":"Risk for asymptomatic household transmission of Clostridioides difficile infection associated with recently hospitalized family members","volume":"28","author":"Miller","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.001_bib40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.gtc.2026.05.001_bib41","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3748\/wjg.15.1554","article-title":"Clostridium difficile associated infection, diarrhea and colitis","volume":"15","author":"Hookman","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib42","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamainternmed.2017.0212","article-title":"Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis","volume":"177","author":"Tariq","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.001_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/cis840","article-title":"Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program","volume":"56","author":"Longtin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/661789","article-title":"Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level?","volume":"32","author":"Fong","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib45","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/cit492","article-title":"Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection","volume":"57","author":"Gould","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2026.05.001_bib48","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1093\/cid\/civ140","article-title":"Current trends in the epidemiology and outcomes of Clostridium difficile infection","volume":"60","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"47","key":"10.1016\/j.gtc.2026.05.001_bib49","first-page":"1201","article-title":"Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.001_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/511798","article-title":"Recommendations for surveillance of Clostridium difficile-associated disease","volume":"28","author":"McDonald","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"14","key":"10.1016\/j.gtc.2026.05.001_bib51","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamainternmed.2013.7056","article-title":"Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011","volume":"173","author":"Chitnis","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.gtc.2026.05.001_bib52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2036.2011.04984.x","article-title":"Outcomes in community-acquired Clostridium difficile infection","volume":"35","author":"Khanna","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.gtc.2026.05.001_bib53","article-title":"Risk factors for community-associated Clostridium difficile infection in adults: a case-control study","volume":"4","author":"Guh","year":"2017","journal-title":"Open Forum Infect Dis. Fall"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib54","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","article-title":"Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078","volume":"47","author":"Goorhuis","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"29","key":"10.1016\/j.gtc.2026.05.001_bib55","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.29.30295","article-title":"Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013","volume":"21","author":"Fawley","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.gtc.2026.05.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102086","article-title":"Ribotype variability of Clostridioides difficile strains in patients with hospital-acquired C. difficile infections, community-acquired C. difficile infections, and colonization with toxigenic and non-toxigenic strains of C. difficile","volume":"60","author":"Kim","year":"2019","journal-title":"Anaerobe"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.001_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajic.2017.11.026","article-title":"Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015","volume":"46","author":"Guh","year":"2018","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.gtc.2026.05.001_bib58","author":"Agency"},{"issue":"2","key":"10.1016\/j.gtc.2026.05.001_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0235","article-title":"Association of a safety program for improving antibiotic use with antibiotic use and hospital-onset Clostridioides difficile infection rates among US hospitals","volume":"4","author":"Tamma","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.gtc.2026.05.001_bib60","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.gtc.2026.05.001_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00698-24","article-title":"Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI\/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures","volume":"68","author":"Wieczorkiewicz","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.001_bib62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/ice.2020.383","article-title":"Inpatient fluoroquinolone use in veterans\u2019 affairs hospitals is a predictor of Clostridioides difficile infection due to fluoroquinolone-resistant ribotype 027 strains","volume":"42","author":"Silva","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"14","key":"10.1016\/j.gtc.2026.05.001_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14144904","article-title":"Impact of an enhanced disinfection protocol on the incidence of Clostridioides difficile infections and antibiotic consumption in a hospital setting: a retrospective intervention study","volume":"14","author":"Tarka","year":"2025","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib64","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2026.05.001_bib65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13017-019-0228-3","article-title":"2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients","volume":"14","author":"Sartelli","year":"2019","journal-title":"World J Emerg Surg"},{"issue":"Suppl 2","key":"10.1016\/j.gtc.2026.05.001_bib66","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.gtc.2026.05.001_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2025.102974","article-title":"Laboratory diagnosis of Clostridioides difficile infection: past, present and future","volume":"93","author":"Barbut","year":"2025","journal-title":"Anaerobe"},{"issue":"7","key":"10.1016\/j.gtc.2026.05.001_bib68","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/ciad334","article-title":"Assessing the impact of 2-Step Clostridioides difficile testing at the healthcare facility level","volume":"77","author":"Turner","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.gtc.2026.05.001_bib69","doi-asserted-by":"crossref","first-page":"798.e1","DOI":"10.1016\/j.cmi.2023.02.008","article-title":"Two-step algorithm-based Clostridioides difficile testing as a tool for antibiotic stewardship","volume":"29","author":"Dbeibo","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/ice.2022.93","article-title":"Healthcare-associated infections in veterans affairs acute-care and long-term healthcare facilities during the coronavirus disease 2019 (COVID-19) pandemic","volume":"44","author":"Evans","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.gtc.2026.05.001_bib71","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/cid\/ciab688","article-title":"The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections","volume":"74","author":"Baker","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.gtc.2026.05.001_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117014","article-title":"Impact of COVID-19 pandemic on toxinogenic Clostridioides difficile infections and correlation with multidrug-resistant bacterial infections","volume":"113","author":"Torrini","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.gtc.2026.05.001_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2024.102836","article-title":"Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: a retrospective cohort study in a tertiary care hospital from 2019 to 2022","volume":"86","author":"Maldonado-Barrueco","year":"2024","journal-title":"Anaerobe"},{"key":"10.1016\/j.gtc.2026.05.001_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2022.102518","article-title":"Clostridioides difficile infection (CDI) during the COVID-19 pandemic","volume":"74","author":"Spigaglia","year":"2022","journal-title":"Anaerobe"},{"issue":"10","key":"10.1016\/j.gtc.2026.05.001_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13102799","article-title":"Retrospective analysis of Clostridioides difficile infection rates and outcomes in hospitalized patients during the COVID-19 pandemic: a unicenter study in reus, Spain","volume":"13","author":"Iftimie","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.001_bib77","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-021-06147-y","article-title":"Burden of clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI","volume":"21","author":"Finn","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.gtc.2026.05.001_bib78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/JCM.01779-16","article-title":"Comparison of Clostridium difficile ribotypes circulating in Australian hospitals and communities","volume":"55","author":"Furuya-Kanamori","year":"2017","journal-title":"J Clin Microbiol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855326000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855326000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:31:20Z","timestamp":1786977080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855326000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0889855326000294"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2026.05.001","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Changing Epidemiology of Clostridioides difficile Infection","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}